SAGE Receives Special Protocol Assessment for Phase 3 STAT-Refractory Statusof SAGE-547; Ultragenyx Announces Initiation of Phase 2 Study of Recombinant Human Beta-Glucuronidase Print E-mail
By William Kent   
Thursday, 06 August 2015 18:54
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 6, 2015.   
Read more...
 
Pfizer Wins EU Approval for $15 Billion Hospira Buy; CEL-SCI Reports Record Monthly Patient Enrollment in July Print E-mail
By Marilyn Mullen   
Wednesday, 05 August 2015 18:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 5, 2015. 
Read more...
 
Protea commences REDIchip shipments; Flexion Expands Supply Capacity for FX006 Print E-mail
By Josh Gee   
Tuesday, 04 August 2015 19:01
Below is a look at some of the headlines for companies that made news in the healthcare sector on August 4, 2015. 
Read more...
 
Neos Resubmits NDA for FDA Review of Orally Disintegrating Tablets; FDA Approves Deltoid Injection Site for Abilify Maintena® Print E-mail
By Josh Gee   
Thursday, 30 July 2015 17:48
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 30, 2015. 
Read more...
 
Viking Therapeutics Reports Will Conduct Phase 2 Trial of VK2809; Mylan Receives Unconditional Clearance from EC on Acquisition of Perrigo Print E-mail
By Josh Gee   
Wednesday, 29 July 2015 19:15
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 29, 2015. 
Read more...
 
Abeona Announces Equity Financing; Aquinox to Provide Update on Phase 2 LEADERSHIP Trial in BPS/IC Print E-mail
By Josh Gee   
Tuesday, 28 July 2015 20:38
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 28, 2015.   
Read more...
 
Aeterna Zentaris Commences Promotional Activities for EMD Serono's Saizen®; Merck Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA™ Print E-mail
By Marilyn Mullen   
Monday, 27 July 2015 19:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 27, 2015.
Read more...
 
Eagle Pharma Announces FDA Accepts RTU Bivalirudin NDA for Filing; Omeros Announces FDA Grants Fast Track Designation for aHUS Print E-mail
By Marilyn Mullen   
Thursday, 23 July 2015 19:20
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 22, 2015.
Read more...
 
Positive Results of Clinical Trials on TRACON; Axovant's RVT-101 Phase 2b Completer Analysis Demonstrates Statistically Significance Print E-mail
By William Kent   
Wednesday, 22 July 2015 17:54
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 22, 2015.  
Read more...
 
Isis Pharma Initiates Clinical Study of ISIS-HTT Rx; Bristol-Myers Announces Additional Phase IIa for BMS-955176 Print E-mail
By William Kent   
Tuesday, 21 July 2015 19:51
Below is a look at some of the headlines for companies that made news in the healthcare sector on July 21, 2015.   
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 369

Newsletter